Quanterix Corp (QTRX) - Total Assets
Based on the latest financial reports, Quanterix Corp (QTRX) holds total assets worth $319.63 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Quanterix Corp - Total Assets Trend (2015–2025)
This chart illustrates how Quanterix Corp's total assets have evolved over time, based on quarterly financial data. Also see Quanterix Corp market capitalisation for the company's overall valuation and market capitalisation.
Quanterix Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
Quanterix Corp's total assets of $319.63 Million consist of 50.7% current assets and 49.3% non-current assets. Review QTRX total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.1% |
| Accounts Receivable | $29.97 Million | 7.2% |
| Inventory | $54.76 Million | 13.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $131.79 Million | 31.5% |
| Goodwill | $26.38 Million | 6.3% |
Asset Composition Trend (2015–2025)
This chart illustrates how Quanterix Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See QTRX stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Quanterix Corp's current assets represent 50.7% of total assets in 2025, a decrease from 77.8% in 2015.
- Cash Position: Cash and equivalents constituted 7.1% of total assets in 2025, down from 31.6% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 31.5% of total assets.
Quanterix Corp Competitors by Total Assets
Key competitors of Quanterix Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
Quanterix Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.40 | 6.68 | 14.73 |
| Quick Ratio | 2.45 | 6.06 | 14.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $120.68 Million | $273.92 Million | $428.24 Million |
Quanterix Corp - Advanced Valuation Insights
This section examines the relationship between Quanterix Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.54 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 3.0% |
| Total Assets | $418.77 Million |
| Market Capitalization | $125.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Quanterix Corp's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Quanterix Corp's assets grew by 3.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Quanterix Corp (2015–2025)
The table below shows the annual total assets of Quanterix Corp from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $418.77 Million | +3.01% |
| 2024-12-31 | $406.53 Million | -5.14% |
| 2023-12-31 | $428.57 Million | -1.16% |
| 2022-12-31 | $433.58 Million | -14.40% |
| 2021-12-31 | $506.51 Million | +86.87% |
| 2020-12-31 | $271.05 Million | +59.48% |
| 2019-12-31 | $169.95 Million | +151.30% |
| 2018-12-31 | $67.63 Million | -26.31% |
| 2017-12-31 | $91.78 Million | +147.27% |
| 2016-12-31 | $37.12 Million | +404.92% |
| 2015-12-31 | $7.35 Million | -- |
About Quanterix Corp
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measureme… Read more